Ventilation function of the lungs in patients after pneumonia associated with coronavirus disease (COVID-19): diagnostic significance of indicators
DOI:
https://doi.org/10.26641/2307-0404.2022.2.260220Ключові слова:
coronavirus disease, COVID-19, pneumonia against COVID-19, post COVID-19 period, pulmonary ventilation function, spirometryАнотація
The aim of our study was to assess the ventilation function of the lungs in persons who had pneumonia after COVID-19 in the Pridneprovie region in January-April 2021, and to determine the types of ventilation disorders and their severity. We examined 41 people who had pneumonia after COVID-19 not earlier than 4 weeks after the onset of clinical symptoms (the median is 48 (40; 68) days). All of them made up the main group (average age – 55.8±5.6 years, men – 21 (51.2%), women – 20 (48.8%)). Patients were divided into two subgroups depending on the severity of the coronavirus disease in the acute period: subgroup 1 included 26 people (average age – 56.1±4.2 years; men – 12 (42.2%), women – 14 (53.8%)) who had a mild course of the acute period of the disease; subgroup 2 – 15 people (average age – 55.2±5.3 years, men – 9 (60.0%), women – 6 (40.0%)), who had a severe course of the acute period of COVID-19. Clinical examination, assessment of dyspnea (The Modified Medical Research Council Dyspnea scale), level of the cough and sputum (by the Savchenko scale), oxygen saturation, spirometry with a bronchodilation test were conducted. Almost half of the patients with pneumonia after COVID-19 had various disorders of the ventilation function of the lungs. In cases with a mild course of the acute period of COVID-19, obstructive changes were significantly more frequent (p=0.035), and in patients with a severe course of the acute period of COVID-19 – restrictive disorders (p=0.002) prevailed. Bronchoobstructive changes in the post-COVID period are most often caused not by decrease in the forced expiratory volume per second but by the ratio of (FEV1)/forced vital capacity (below 0.7) and/or by the presence of visualized changes in the “flow-volume” curve.
Посилання
Horoshko VI, Hordienko OV. [Rehabilitation of lung damage in patients after coronavirus infection COVID-19]. Prospects, problems and current achie-vements in the development of physical culture and sports in Ukraine: Proceedings of the IV All-Ukrainian electronic Conference "COLOR OF SCIENCE"; 2021 Jan 29; Vinnytsia, Ukraine; 2021:280-5. Ukrainian.
Pertseva TA, Konopkina LI. [Fundamentals of the study of the ventilation function of the lungs: clinical and diagnostic value. Methodical manual for doctors and students of medical schools]. Dnepropetrovsk: ArtPress; 2008. p. 66. Russian.
PylypenkoMM, Khomenko OY. [Pathophysio-logy of hypoxemia and dyspnea in severe pneumonia]. Ukr. Pulmonoloh. zhurnal. 2020;(2):19-26. Ukrainian. doi: https://doi.org/10.31215/2306-4927-2020-108-2-19-26
[On approval of the protocol "Provision of medi-cal care for the treatment of coronavirus disease (COVID-19)": Order of the Ministry of Health of Ukraine from 2.04.2020 No. 762.]. Pub. L. No. 3094. (Dec 31, 2020). Ukrainian. Available from: https://moz.gov.ua/uploads/5/28069-dn_3094_31_12_2020_dod.pdf
[On approval of the protocol "Amendments to the Standards of Medical Care “Coronavirus Disease (COVID19)": Order of the Ministry of Health of Ukraine from 2.04.2020 № 762]. Pub. L. No. 638). (April 06, 2021). Ukrainian. Available from: https://moz.gov.ua/uploads/5/29766-dn_638_06_04_2021_dod.pdf
Savchenko VM. [Formalized system of basic clinical indicators for assessing the condition of patients with chronic non-obstructive and obstructive pulmonary diseases]. Ukr. Pulmonoloh. zhurnal. 2001;(2):46-50. Russian.
Fetisov VS. [STATISTICA statistical data analy-sis package]. Nizhyn: NDU im. M Hoholia; 2018. p. 114. Ukrainian.
Feshchenko YuI, Golubovska OA, Dziub¬lyk AYa, Gavrysyuk VK, Dziublyk YaA, Liskina IV. [Pulmonary disease in COVID-19] Ukr. Pulmonol. J. 2021;1:5-14. Ukrainian. doi: https://doi.org/10.31215/2306-4927-2021-29-1-5-14
Amin MT, Fatema K, Arefin S, Hussain F, Bhow-mik DR, Hossain MS. Obesity, a major risk factor for immunity and severe outcomes of COVID-19. Biosci Rep. 2021 Aug 27;41(8):BSR20210979. doi: https://doi.org/10.1042/BSR20210979
Blanco JR, Cobos-Ceballos MJ, Navarro F, Sa-njoaquin I, Arnaiz de Las Revillas F, Bernal E, et al. Pul-monary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect. 2021 Jun;27(6):892-6. doi: https://doi.org/10.1016/j.cmi.2021.02.019
Carfì A, Bernabei R, Landi F. Persistent Symp-toms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-5. doi: https://doi.org/10.1001/jama.2020.12603
Casanova C, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, et al. COPD History Assessment in Spain (CHAIN) Cohort. Dif-ferential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD. Chest. 2015 Jul;148(1):159-68. PMID: 25612228. doi: https://doi.org/10.1378/chest.14-2449
Graham BL, Steenbruggen I, Miller MR. Standar-dization of Spirometry 2019 Update. An Official Ame-rican Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70-e88. doi: https://doi.org/10.1164/rccm.201908-1590ST
Henry BM, de Oliveira MHS, Benoit S, Pleba-ni M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020 Jun 25;58(7):1021-8. doi: https://doi.org/10.1515/cclm-2020-0369
Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020 Jun 29;21(1):163. doi: https://doi.org/10.1186/s12931-020-01429-6
Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021 Mar;75(3):e13746. doi: https://doi.org/10.1111/ijcp.13746
Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020 Aug;25:100463. doi: https://doi.org/10.1016/j.eclinm.2020.100463
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2022 Медичні перспективи
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.